HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matthews, P. M. Articles by Arnold, D. L. Search for Related Content PubMed PubMed Citation Articles by Matthews, P. M. Articles by Arnold, D. L.

In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondria1 disease

Montreal Neurological Institute. McGill University. Montreal. PQ. Canada.

We have investigated the sensitivity and specificity of a rapid phosphorus magnetic resonance spectroscopy (MRS) protocol for detecting metabolic abnormalities in vivo in skeletal muscle of patients with mitochondrial disease. We examined 17 patients with mitochondrial myopathies. Sixteen had only mild or minimal myopathic signs and symptoms. Phosphorus magnetic resonance spectra from the resting gastrocnemius muscles showed an abnormal intracellular energy state (marked by an increased intracellular inorganic phosphate concentration) in 14/17. In 3/17, this was associated with a decreased phosphocreatine concentration. We also studied 20 patients with other diseases of muscle (inflammatory myopathies, metabolic myopathies, muscular dystrophies, and myasthenia gravis) that can present with similar clinical features. Spectra showed increased intracellular inorganic phosphate concentrations in 6/20. All of these muscle diseases were associated with evidence of muscle fiber necrosis. Abnormalities in the muscle energy state in these cases may be due to secondary mitochondrial dysfunction. Except for cases of polymyositis and dermatomyositis, these 6 other myopathies could be readily distinguished from the mitochondrial myopathies on the basis of the clinical examination and blood tests. We conclude that phosphorus MRS of resting muscle is practical in a clinical setting and has a useful sensitivity and specificity for mitochondrial myopathies when used in conjunction with standard noninvasive tests.

Address correspondence and reprint requests to Dr. D.L. Arnold, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, PQ, H3A-2R4, Canada.

Presented in part at the 41st annual meeting of the American Academy of Neurology, Chicago, IL, April 1989.

Received January 26, 1990. Accepted for publication in final form May 21, 1990.

This article has been cited by other articles:

				S.-F. Ko, C.-C. Huang, M.-J. Hsieh, S.-H. Ng, C.-C. Lee, C.-C. Lee, T.-K. Lin, M.-C. Chen, and L. Lee 31P MR Spectroscopic Assessment of Muscle in Patients with Myasthenia Gravis before and after Thymectomy: Initial Experience Radiology, April 1, 2008; 247(1): 162 - 169. [Abstract] [Full Text] [PDF]

				B. Walzel, O. Speer, E. Boehm, S. Kristiansen, S. Chan, K. Clarke, J. P. Magyar, E. A. Richter, and T. Wallimann New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E390 - E401. [Abstract] [Full Text] [PDF]

				T. D. Jensen, P. Kazemi-Esfarjani, E. Skomorowska, and J. Vissing A forearm exercise screening test for mitochondrial myopathy Neurology, May 28, 2002; 58(10): 1533 - 1538. [Abstract] [Full Text] [PDF]

				H. Sprott, R. Rzanny, J. R. Reichenbach, W. A. Kaiser, G. Hein, and G. Stein 31P magnetic resonance spectroscopy in fibromyalgic muscle Rheumatology, October 1, 2000; 39(10): 1121 - 1125. [Abstract] [Full Text] [PDF]

				R. C. Griggs and G. Karpati Muscle Pain, Fatigue, and Mitochondriopathies N. Engl. J. Med., September 30, 1999; 341(14): 1076 - 1078. [Full Text]

				R. Lodi, J. M. Cooper, J. L. Bradley, D. Manners, P. Styles, D. J. Taylor, and A. H. V. Schapira Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia PNAS, September 28, 1999; 96(20): 11492 - 11495. [Abstract] [Full Text] [PDF]

				M. Tarnopolsky and J. Martin Creatine monohydrate increases strength in patients with neuromuscular disease Neurology, March 1, 1999; 52(4): 854 - 854. [Abstract] [Full Text]